Neuberger Berman Group LLC Cytosorbents Corp Transaction History
Neuberger Berman Group LLC
- $118 Billion
- Q2 2024
A detailed history of Neuberger Berman Group LLC transactions in Cytosorbents Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,536,514 shares of CTSO stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,536,514
Previous 1,912,566
19.66%
Holding current value
$1.38 Million
Previous $1.82 Million
40.8%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
17.1MCall Options Held
10.1KPut Options Held
500-
Avenir Corp Washington, DC2.97MShares$2.67 Million0.21% of portfolio
-
Skylands Capital, LLC2.76MShares$2.48 Million0.6% of portfolio
-
Granahan Investment Management, LLC Waltham, MA2.66MShares$2.4 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.75 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.63MShares$1.46 Million0.45% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $39.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...